Riskpilot← Back to searchSign inGet full accessDr. Violeta konsult AB
ABActiveOrg 5592886443Linvägen 25Medical specialists activities · NACE 8622Est. 20200 employees
Revenue 2025
SEK -2
-100% vs 2024
EBITDA margin
444100.0%
-101% vs 2024
Equity ratio
86.9%
Financial strength
Net profit 2025
SEK 105K
-71% vs 2024
| Revenue | SEK -2 | -100% |
| EBITDA | SEK -9K | -101% |
| Net profit | SEK 105K | -71% |
| Total assets | SEK 296K | -62% |
| Equity | SEK 257K | -34% |
| Employees | 0 | — |
Legal name
Dr. Violeta konsult AB
Org number
5592886443
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
9 december 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att tillhandahålla specialistkompetens inom psykiatri (sluten och öppenvård) samt därmed förenlig verksamhet.
Address
Linvägen 25
Email
stinguliliana@yahoo.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 160 | 503 | 440 | 639 | −0 |
| Staff expenses | — | −14 | −0 | −3 | −0 |
| EBITDA | 104 | 443 | 426 | 620 | −9 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 104 | 443 | 426 | 620 | −9 |
| Net financials | — | 0 | 0 | −4 | −2 |
| Profit before tax | 104 | 443 | 426 | 462 | 134 |
| Tax | −22 | −91 | −88 | −96 | −29 |
| Net profit | 82 | 352 | 338 | 366 | 105 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 178 | 613 | 634 | 776 | 296 |
| Equity | 107 | 377 | 365 | 392 | 257 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 71 | 236 | 269 | 229 | 29 |
| Total debt | 71 | 236 | 269 | 229 | 29 |
EBITDA margin
-888200.0%
This company
15.8%
Market median
-5621619% vs market
20212025
Equity ratio
86.9%
This company
38.2%
Market median
+127% vs market
20212025
Return on equity
41.0%
This company
18.4%
Market median
+123% vs market
20212025
Net profit margin
10544100.0%
This company
8.1%
Market median
+130173974% vs market
20212025
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (2) | ||
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr. Violeta konsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Patrik Carl Johannes Tavassoli | Board of Directors | 0 companies |
| Liliana-Violeta Cuzub | Board of Directors | 0 companies |
| Jens Gunnar Rosenblad | Deputy Board Member | 0 companies |
| Anton Cuzub | Deputy Board Member | 0 companies |